| PSQ | SPXU | PSQ / SPXU | |
| Gain YTD | -9.940 | -23.689 | 42% |
| Net Assets | 759M | 432M | 176% |
| Total Expense Ratio | 0.95 | 0.90 | 106% |
| Turnover | N/A | N/A | - |
| Yield | 4.26 | 6.79 | 63% |
| Fund Existence | 20 years | 17 years | - |
| PSQ | SPXU | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 90% | N/A |
| Stochastic ODDS (%) | 3 days ago 85% | 3 days ago 90% |
| Momentum ODDS (%) | 3 days ago 88% | 3 days ago 90% |
| MACD ODDS (%) | N/A | 3 days ago 86% |
| TrendWeek ODDS (%) | 3 days ago 86% | 3 days ago 90% |
| TrendMonth ODDS (%) | 3 days ago 85% | 3 days ago 90% |
| Advances ODDS (%) | 5 days ago 81% | 11 days ago 86% |
| Declines ODDS (%) | 3 days ago 85% | 3 days ago 90% |
| BollingerBands ODDS (%) | 3 days ago 90% | 3 days ago 90% |
| Aroon ODDS (%) | 3 days ago 84% | N/A |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| VRGWX | 936.97 | 7.54 | +0.81% |
| Vanguard Russell 1000 Growth Index I | |||
| BQLCX | 23.42 | 0.17 | +0.73% |
| Bright Rock Quality Large Cap Instl | |||
| GVIRX | 20.07 | 0.12 | +0.60% |
| Goldman Sachs US Eq Div and Premium Inv | |||
| PIEQX | 22.30 | -0.17 | -0.76% |
| T. Rowe Price International Eq Index | |||
| RYOAX | 66.89 | -1.55 | -2.26% |
| Rydex Biotechnology H | |||